Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Legislation
|
Business
|
Products
|
Generics
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
Access to medicines concerns in EU-India trade agreement
12 March 2010
The international humanitarian body Médecins Sans Frontières (MSF) has written to the Indian prime minister, Dr Manmohan Singh , expressing concern that the EU-India free trade agreement, which will have its sixth negotiating round in Brussels in ...
 
Access to medicines concerns in EU-India trade agreement
12 March 2010
The international humanitarian body Médecins Sans Frontières (MSF) has written to the Indian prime minister, Dr Manmohan Singh , expressing concern that the EU-India free trade agreement, which will have its sixth negotiating round in Brussels in April, will contain intellectual property (IP) ...
Swifter market access for drugs will require a revolution
11 March 2010
The plenary session at the Drug Information Association’s Euromeeting in Monaco this week took the curious form of an enforced debate on pharmaceutical R&D productivity between representatives from the industry and regulatory authorities. The motion was: “The house believes that the process of ...
 
Access to medicines concerns in EU-India trade agreement
12 March 2010
The international humanitarian body Médecins Sans Frontières (MSF) has written to the Indian prime minister, Dr Manmohan Singh , expressing concern that the EU-India free trade agreement, which will have its sixth negotiating round in Brussels in April, will contain intellectual property (IP) ...
Around 300 drugs exempt from regular price cut under new Japanese provisions
10 March 2010
Around 300 products will escape a reduction in the next regular revision of reimbursement prices for prescription drugs in Japan on April 1st because they meet certain criteria under complex new rules being adopted on a trial basis this year. Details of the revision released by the ministry of ...
 
Swifter market access for drugs will require a revolution
11 March 2010
The plenary session at the Drug Information Association’s Euromeeting in Monaco this week took the curious form of an enforced debate on pharmaceutical R&D productivity between representatives from the industry and regulatory authorities. The motion was: “The house believes that the process of ...
Counterfeiters beware: WHO shows poor countries how to procure antimalarials
10 March 2010
Establishments that produce substandard or counterfeit antimalarials will find it harder to sell their products to developing countries after the World Health Organization published new guidelines this week spelling out how to buy quality-made artemisinin-based combination therapies (ACTs), the ...
 
EXPERT VIEW
Keeping the faith with anticancers
12 March 2010
Peter Charlish
It has been a bad week for anticancer drug development, with two late-stage projects coming to ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

Market Insight - Pharma sector in Turkey to shrink 25% under tough conditions
02 March 2010

The pharmaceutical industry has long eyed Turkey as one of its key emerging markets, but recent ...

Market Insight - Power of observation propels comparative effectiveness research into the mainstream
02 March 2010

US agencies are making inroads in the use of comparative effectiveness research to support more ...

Private investment round-up: January 2010
16 February 2010
Private investments began 2010 in a much more positive fashion than at the start of 2009, but were ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Face to Face with Sandoz's "growth guy" Jeff George
04 March 2010
Eleanor Malone
Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

Focus on Pharmaceutical Sales
26 September 2008
Section 1 - Dodging the bullet - Pharmaceutical and biotech companies are particularly vulnerable ...

© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm